Proposed Data Collections Submitted for Public Comment and Recommendations, 36345-36346 [E6-10025]
Download as PDF
<![CDATA[
36345
Federal Register / Vol. 71, No. 122 / Monday, June 26, 2006 / Notices
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Colorectal Cancer Screening
Demonstration Program—New—
Division of Cancer Prevention and
Control (DCPC), National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC, DCPC is requesting
approval to collect individual patientlevel screening, diagnostic, and
treatment data in association with a new
colorectal cancer screening
demonstration program. DCPC is
funding 5 cooperative agreements from
fiscal year (FY) 2005–2008 for
implementation of new colorectal
cancer (CRC) demonstration programs.
These 3-year demonstration programs
are designed to increase populationbased CRC screening among persons 50
years and older with low income and
inadequate or no health insurance
coverage in a geographically defined
area.
Colorectal Cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States, following lung
Submitted data must contain no patient
identifiers.
All programs will additionally submit
annual cost data to CDC to be used to
monitor cost and cost-effectiveness over
the 3-year program period.
The additional burden to these
respondents will be small, since CDC
will only select programs that are
already performing some CRC screening,
and will therefore already be collecting
these types of data. Data collection for
both patient-level and cost data will
continue over the 3 years of the
demonstration programs.
In the burden table below, two data
collection forms will be used: Patientlevel clinical data collection forms and
cost data collection forms. The data will
be collected from the 5 cooperative
agreement recipients, i.e., the
respondents. The estimated number of
responses represents the number of
patients receiving clinical services per
recipient program, one report per
patient per quarterly reporting period
(estimated at 70 patients per program
per quarter). This would result in an
estimated annualized burden for the
quarterly reports of 583 hours.
Additionally, respondents will report
annual cost data. For reporting the
annual cost data, the respondents will
submit only one report each for the
entire year.
There is no cost to respondents other
than their time.
cancer. Based on scientific evidence
which indicates that regular screening is
effective in reducing CRC incidence and
mortality, regular CRC screening is now
recommended for average-risk persons
with one or a combination of the
following tests: Fecal occult blood
testing (FOBT), flexible sigmoidoscopy,
colonoscopy, and/or double-contrast
barium enema (DCBE). Fecal
immunochemical testing (FIT) is
considered an acceptable alternative to
FOBT. In the absence of evidence
indicating a single most effective test,
selected programs will be able to choose
which screening test(s) they will use
from the above list of recommended
tests.
All funded programs will be required
to submit patient-level data on CRC
screening and diagnostic services
provided as part of this demonstration
project. This information will be used to
assess the quality and appropriateness
of the services delivered.
Programs that receive CDC funding to
provide screening and diagnostic
services will collect individual patientlevel data to capture demographic
information, clinical services and
outcomes, and submit these data to CDC
on a quarterly basis. While CDC funds
will not be used for treatment, programs
will need to monitor treatment and
document that patients are receiving
appropriate treatment services.
ESTIMATED ANNUALIZED BURDEN HOURS
Form type
Number of
respondents
Number of responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Quarterly patient-level clinical data ..................................................................
Annual cost data ..............................................................................................
5
5
280
1
25/60
25/60
583
2
........................
........................
........................
585
Total ..........................................................................................................
Dated: June 20, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–10024 Filed 6–23–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–06BJ]
rwilkins on PROD1PC63 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
VerDate Aug<31>2005
17:00 Jun 23, 2006
Jkt 208001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
E:\FR\FM\26JNN1.SGM
26JNN1
36346
Federal Register / Vol. 71, No. 122 / Monday, June 26, 2006 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Experiment in Mapping Behavioral
Risk Factors Surveillance Survey
(BRFSS) Data—NEW—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The purpose of this study is to design
and implement a Web-based interview
examining the differential effectiveness
of presenting BRFSS data in two
different mapping formats, choropleth
versus isopleth maps. Traditionally,
geospatial data are presented in
categories. To maintain a low survey
burden for each participant, the
instrument will include only 4
questions for each of 10 maps. The
interview will also include additional
questions about respondent’s
preferences for map types and
background characteristics. The survey
instrument will be comprised of 50
items, including the 40 map questions,
4 questions about users’ preferences for
different map formats, and 6 questions
about their educational and professional
background and demographic
characteristics. Analysis of the data will
assess 4 key areas to determine which
type of map is ideal for presenting
BRFSS data:
1. Rate retrieval
2. Pattern recognition
3. Ease of understanding
4. User preferences
The results of these analyses will be
presented in a final report to be
submitted to the CDC. There are no
costs to respondents other than their
time.
choropleth maps, where defined
geographic units, such as county or state
boundaries, are filled with a uniform
color or pattern. Choropleth maps
present data as geographic areas shaded
with intensity proportional to the data
values associated with those areas. Such
maps are appropriate for data that have
been scaled or normalized.
Alternatively, geospatial data can be
displayed using isopleth maps, in which
the data are not aggregated to predefined geographic units, but instead
are ‘‘smoothed’’ across adjacent
geographic boundaries. Such maps may
show county or state boundaries, but
different categories of data are not
defined by these geographic units. Little
empirical research has examined the
differential effectiveness of choropleth
versus isopleth maps. In particular,
researchers know little about how the
two different mapping techniques affect
the user’s ability to extract information
from the map.
The Web-based interview will present
both choropleth and isopleth maps
displaying BRFSS data in seven color
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Number of
respondents
Number of responses per
respondent
Average
burden per
response
(in hrs.)
Total burden
hours
Experiment in Mapping BRFSS Data ..............................................................
400
1
30/60
200
........................
........................
........................
200
Total ..........................................................................................................
Dated: June 19, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–10025 Filed 6–23–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–05BL]
rwilkins on PROD1PC63 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
VerDate Aug<31>2005
17:00 Jun 23, 2006
Jkt 208001
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Worksheet for Medical Conditions
among Refugees and Immigrants—
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
New—National Center for Infectious
Diseases (NCID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Clearance is being requested for a
‘‘Worksheet for Medical Conditions
among Refugees and Immigrants’’ for
state and local health refugee
coordinators to identify specific medical
conditions of public health importance
in newly arrived refugees and
immigrants.
CDC requests notification of specific
medical conditions listed on the
worksheet, including Class A and B
health conditions not recognized
overseas, and substantial discrepancies
in the overseas and U.S. based medical
evaluations. Section 412 of the
Immigration and Nationality Act (INA)
(8 U.S.C. 1522(b)(4)) authorizes the
Secretary of Health and Human Services
Department of Health and Human
Services (DHHS) to: (A) Assure that an
adequate number of trained staff are
available at the location at which the
refugees enter the United States to
assure that all necessary medical
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 71, Number 122 (Monday, June 26, 2006)]
[Notices]
[Pages 36345-36346]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-10025]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-06-06BJ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c)
[[Page 36346]]
ways to enhance the quality, utility, and clarity of the information to
be collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology. Written
comments should be received within 60 days of this notice.
Proposed Project
Experiment in Mapping Behavioral Risk Factors Surveillance Survey
(BRFSS) Data--NEW--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The purpose of this study is to design and implement a Web-based
interview examining the differential effectiveness of presenting BRFSS
data in two different mapping formats, choropleth versus isopleth maps.
Traditionally, geospatial data are presented in choropleth maps, where
defined geographic units, such as county or state boundaries, are
filled with a uniform color or pattern. Choropleth maps present data as
geographic areas shaded with intensity proportional to the data values
associated with those areas. Such maps are appropriate for data that
have been scaled or normalized. Alternatively, geospatial data can be
displayed using isopleth maps, in which the data are not aggregated to
pre-defined geographic units, but instead are ``smoothed'' across
adjacent geographic boundaries. Such maps may show county or state
boundaries, but different categories of data are not defined by these
geographic units. Little empirical research has examined the
differential effectiveness of choropleth versus isopleth maps. In
particular, researchers know little about how the two different mapping
techniques affect the user's ability to extract information from the
map.
The Web-based interview will present both choropleth and isopleth
maps displaying BRFSS data in seven color categories. To maintain a low
survey burden for each participant, the instrument will include only 4
questions for each of 10 maps. The interview will also include
additional questions about respondent's preferences for map types and
background characteristics. The survey instrument will be comprised of
50 items, including the 40 map questions, 4 questions about users'
preferences for different map formats, and 6 questions about their
educational and professional background and demographic
characteristics. Analysis of the data will assess 4 key areas to
determine which type of map is ideal for presenting BRFSS data:
1. Rate retrieval
2. Pattern recognition
3. Ease of understanding
4. User preferences
The results of these analyses will be presented in a final report
to be submitted to the CDC. There are no costs to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hrs.) hours
----------------------------------------------------------------------------------------------------------------
Experiment in Mapping BRFSS Data............ 400 1 30/60 200
-------------------------------------------------------------------
Total................................... ............... ............... ............... 200
----------------------------------------------------------------------------------------------------------------
Dated: June 19, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-10025 Filed 6-23-06; 8:45 am]
BILLING CODE 4163-18-P
